Case Report
A 57-year-old male solicitor's clerk came to the Brompton Hospital in July 1973 with a five-week history of expiratory wheezing and cough productive of a small amount of transparent, frothy sputum. He felt perfectly well and had noticed no change in his effort tolerance. In 1957 he gave up smoking but for 18 years before that had smoked about 20 cigarettes a day. He had never before noticed wheezing or any other feature suggesting chronic bronchitis or asthma and had had no serious illness.
The only abnormal physical signs were coarse crepitations at the base of the left lung, and enlargement of the liver whose smooth edge was not tender but was palpable two fingerbreadths below the costal margin. The chest radiograph showed patchy consolidation of the left lower lobe, particularly of its apical segment. (A chest radiograph one year earlier was normal.) His haemoglobin was 164 g/dl and packed cell volume 0-54. The total white cell count, differential count, ESR, liver function tests, serum urea, and electrolytes were normal. Complementfixation tests for common viruses and mycoplasma were negative. The forced expiratory volume in 1 second (FEV1) was 2400 ml (predicted normal 3040 ml) and the vital capacity (VC) 3850 ml (predicted normal 4380 ml). Sputum culture was sterile for common pathogens and for M. tuberculosis. On seven occasions cytological examination of the sputum failed to reveal neoplastic cells. At bronchoscopy, the mucosa appeared normal, the only abnormality being a large amount of watery fluid in the left lower lobe bronchus. No biopsy was taken, and in trap specimens of secretion no malignant cells were identified.
The patient was discharged on antibiotics and the radiographic appearance slightly improved, but within a week he was producing larger quantities of watery sputum, which he expectorated simply by bending forwards and without coughing. When he was readmitted early in November 1973 he had been producing about 700 ml of sputum each day for six weeks, sputum which he complained tasted very salty. This troubled him most during the night since he was awakened several times by discomfort relieved by bringing up about a cupful of sputum. He still felt well, but now complained of some shortness of breath on walking at a fast pace. He had lost 2i kg weight over the previous two months.
On examination the liver was larger but still smooth and not tender and other investigations showed little change, save that the total serum protein of 7-3 g/dl fell to 61 g/dl at the end of November, with normal albumin and globulin fractions. The FEV1 and VC were both lower, being 1870 ml and 2640 ml respectively and the transfer factor (TLCO) was low, 3-8 mmol min-1 K Pa-1 (normal 8-7). The radiograph showed increased shadowing in the left lower lobe (see fig 1) , and two weeks later some abnormal shadows were seen for the first time in the right lower lobe. Alveolar cell carcinoma was diagnosed from positive cytological findings on four of six sputum specimens. For three weeks all sputum was collected and detailed volumetric, rheological, and chemical analyses were carried out.
Since the tumour was thought to be inoperable, treatment, that unfortunately failed, was directed to reducing sputum volume-fluid restriction, prednisone 40 mg daily, subcutaneous atropine to tolerance levels, and cytotoxic chemotherapy with cyclophosphamide, 5-fluorouracil, vincristine, and procarbazine in combination. The patient was discharged on 6 December 1973 on 40 mg of prednisone a day but his condition deteriorated rapidly and he died at home later that month. Permission for a postmortem examination was not granted.
Sputum Studies
All sputum produced was collected so that the daily volume could be measured, but only that sputum produced between 6 am and 6 pm was used in rheological and chemical studies. During these 12 hours sputum was collected over three-hour periods. At the end of the three hours aliquots for osmolality (Advanced Instruments Ltd osmometer model 3L) and viscosity studies (Ferranti-Shirley cone and plate viscometer over a shear rate of 0 to 1800 sec-1) were taken and the tests made immediately. The remainder of the sputum was frozen at -20°C and stored at the same temperature for chemical analysis. The following estimations were carried out: total macromolecular material (Warren, 1959) , N-acetyl neuraminic acid (NANA) (Warren, 1959) , methylpentose-fucose (Gibbons, 1955) , sulphate (Antonopoulos, 1962) , mannose (Das, 1974) . Total proteins (biuret method of Gomall, Bardawill, and David, 1949) , albumin (Doumas, 1971) , and calcium (AutoAnalyzer) estimations were carried out by the Biochemistry Department of the Brompton Hospital.
Fresh sputum samples were centrifuged at 5000 g at 4°C for 1800 seconds (MSE automatic Superspeed 65 ultracentrifuge).
Results
In our patient the daily sputum volume and its macroscopic appearance were typical of bronchorrhoea-a watery, transparent fluid topped by copious froth. The sputum volume varied from 630 ml to 1 litre, with a mean value of 843 ml, being more than in other cases of bronchorrhoea we have studied. Neither the rate of sputum production nor the viscosity and chemical constituents showed the circadian rhythm seen in other diseases (Charman, 1974; Lopez-Vidriero, 1974 Reid, 1974) , mannose content of the single sputum studied was significantly lower levels were found in our patient 0 094 mmol/l, well below serum levels and about for dry weight (mg/ml) NANA and fucose (as a 10 times lower than that found in other diseases percentage and mmol/l). No significant difference (table I) . Other chemical estimations included total was found for the NANA/fucose ratio (table II) . proteins (0-6 g/dl), albumin (0 3 g/dl) and calcium Viscosity showed a significant correlation with (1 7 mmol/dl). Total proteins and albumin levels dry weight (p > 0 001) and fucose (mmol/l P > were within the chronic bronchitic range (Brogan, 0 01) as has been reported for other diseases (Lopez- Ryley, Allen, and Hutt, 1971; Ryley and Brogan, Vidriero, Charman, Keal, de Silva, and Reid, 1973) ; 1973) but calcium was found to be higher than in a significant correlation was not found with NANA chronic bronchitic sputum (Brogan et al, 1971) .
(mmol/l) although a positive correlation between this Thus the most characteristic feature of sputum level and viscosity has been reported by many from any bronchorrhoea patient, when compared workers in various epithelial secretions (Gibbons, with sputum from other diseases such as chronic 1959; Gibbons and Glover, 1959; Odin, 1955; bronchitis, asthma, bronchiectasis, and cystic Munies, Grubb, and Caliari, 1968; Keal and Reid, fibrosis, is still the sputum volume since some of the 1972; Lopez-Vidriero et al, 1973 (table lII) . The NANA content was low in whole sputum and in both of its phases, and in contrast to other types of bronchorrhoea and chronic bronchitis the NANA/fucose ratio was lower in the gel phase than in the sol (Lopez-Vidriero, 1974) .
The osmolality of sputum was higher than is usual in bronchorrhoea or asthma and within the chronic bronchitis range (table I) .
Samples of sputum with large amounts of froth were sent to Professor R. E. Pattle for surfactant studies. He reported that the froth was of a gelatinous nature consisting of typical alveolar bubbles lined with lung surfactant as shown by stability tests and treatment with antifoam.
In our patient continuous prednisone for six weeks and also subcutaneous atropine, fluid restriction, and a course of four cytotoxic agents made no impression on the daily sputum volume. There Table IV Sputum, plasma, and urine osmolality (milliosm/kg) before and during fluid restriction
Discussion
The patient presented here had bronchorrhoea by definition since his daily sputum production was in excess of 100 ml (Keal, 1971a ). The chemical and rheological studies indicate that this patient's bronchial fluid was not saliva but partly bronchial secretion partly serum transudate. The viscosity was higher than that of either saliva or serum and fell within the range found in other types of bronchorrhoea and hence lower than expected for mucoid chronic bronchitic sputum. Since fucose comes from epithelial glycoprotein not from serum, the significant correlation between viscosity and fucose but not with NANA suggests that a secreted glycoprotein, perhaps a mainly neutral one, was responsible for the rheological properties of the patient's sputum.
It has been reported that the gel phase of chronic bronchitic sputum contains the bronchial glycoprotein, some serum proteins and glycoproteins bound to the bronchial glycoprotein , while in the sol phase are found any soluble components of bronchial secretion and also serum proteins (Ryley and Brogan, 1973) . In our patient, taking absolute values and the NANA/ fucose ratio in whole sputum and after centrifugation in sol and gel phases, the results suggest that our patient's sputum contained bronchial secretion but that the glycoprotein secreted was less acid than usual and mainly a neutral fucomucin, eg, a blood group substance. These findings agreed with other studies reported by Warfringe (1955) , Gernez-Rieux, Voisin, Macquet, Clayes, Piat, and Fournier (1961 ), Asselain et al (1969 ), and Voisin (1969 in patients with alveolar cell carcinoma.
The surfactant studies seem to indicate an alveolar origin for most of the fluid since agitation of the liquid part of the sputum did not result in stable bubble formation, suggesting that epithelial glycoproteins arise from the tumour cells lining the alveoli and the failure to respond to treatment suggests that this may be autonomous.
The daily sputum production, viscosity levels, and NANA/fucose ratio fell within the range found in other cases of bronchorrhoea associated with chronic bronchitis, asthma, or bronchiectasis, while the dry weight, NANA, and fucose content were lower than in other types of bronchorrhoea. The osmolality was significantly higher, possibly due to a high ionic concentration, a chemical feature reported by Gernez-Rieux and his colleagues (1961) in a case of bronchorrhoea associated with alveolar cell carcinoma.
Treatment of bronchorrhoea associated with alveolar cell carcinoma or other pulmonary diseases may be directed either to reducing the bronchial secretion as by parasympathetic blocking drugs or corticosteroids or to decreasing the serum transudate as by antihistamine drugs or corticosteroids, depending on the cause of the excessive sputum.
There is no information on the effect of resection in alveolar cell carcinoma.
Organ culture studies have shown that in certain patients corticosteroids reduce the secretion of mucus by the bronchial glands, possibly due to a membrane effect (Sturgess, 1972) . Also corticosteroids have been successful in treating some cases of bronchorrhoea associated with extrinsic or intrinsic asthma (Keal, 1971a ), especially when the sputum level of NANA is low. A less dramatic response was observed with antihistamine drugs and subcutaneous atropine in bronchorrhoea with extrinsic asthma (Keal, 1971b) .
In only a few cases of bronchorrhoea associated withalveolar cell carcinoma has treatment of sputum volume been attempted and any success has been temporary. In one case infiltration of the stellate ganglion was followed by reduction of the sputum volume from 300 ml to 150 ml for two weeks (Bourgeois, Delarue, Garaix, and Brien, 1950) . Gernez-Rieux et al (1961) reported some decrease after subcutaneous injections of atropine and oral belladona. Siltzbach (personal communication) found that ACTH produced a dramatic, but temporary, reduction in the sputum volume of four patients with bronchorrhoea associated with alveolar cell carcinoma. In other cases treated with atropine, corticosteroids, infiltration of the stellate ganglion, intravenous procaine, radiotherapy and antihistamine, no reduction in sputum was obtained (Bourgeois et al, 1950; Rubinstein and Pilheu, 1954; Turiaf, Marland, and Sors, 1957; Gemez-Rieux et al, 1961 ).
In our patient, although the NANA level in sputum was low, corticosteroids failed to reduce the volume. 
